Business Development

Our business development strategy is grounded in our desire to bring innovative, life-enhancing therapies to people with cancer around the world.

For more than 25 years, Takeda has been dedicated to pursuing innovation in oncology at all stages, from early discovery to late-stage development. However, our success has been enabled by strategic partnerships that complement our strengths and drive science forward.

In fact, Takeda Oncology was made possible by uniting the focused oncology expertise of Millennium Pharmaceuticals with Takeda Pharmaceutical Company Limited, Japan's largest pharmaceutical company, in 2008.